Marcie A. Goldstein

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $287.5 million initial public offering of 12,234,042 common shares…

Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by LGI Homes, Inc. of its shares of common stock for up to an aggregate amount of $25 million…

Davis Polk advised The Royal Bank of Scotland Group plc (RBSG), a public limited company incorporated under the laws of Scotland, in connection with its SEC-registered offering of $2.65…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Bunge Limited Finance Corp., a wholly owned subsidiary of Bunge Limited, of $700 million…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $121.4 million initial public offering of 7,590,000 shares of common stock…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $719 million initial public offering by Patheon N.V. (“Patheon”). The IPO comprised…

Davis Polk advised the sole underwriter in connection with the approximately $260 million secondary offering of 12,500,000 shares of common stock of Summit Materials, Inc. by certain…

Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…

Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000 shares of common stock of Spark Therapeutics, Inc. (“Spark”),…